ArchiMed has invested in plasmid DNA and protein therapeutics developer Xpress Biologics, with the intention of implementing a tenfold production capacity increase for the company.
Series B takes French food-tech delivery startup’s total funding to USD 105m
Attendees at IPEM 2022 are bracing for challenging fundraising market to continue into 2023
Investor hires James Charalambides from Sixth Street to lead new strategy out of London
Mid-market GP is deploying 2020 Fun IV in primary carve-out from French laboratories company